CJC-1295 and Ipamorelin are combined in therapy because they are known to work very well together. Generally, when combined, we see a 3-5 fold increase in growth hormone release over ipamorelin alone. This will increase the benefits of your peptide therapy over using a single peptide alone.

CJC-1295 is an incredibly effective peptide which works by stimulating the release of your own body’s growth hormones (which drop quickly after the age of 30). Research has shown that CJC-1295 can increase growth hormone levels by 200-1000% and the elevated growth hormone production continued for up to 6 days.

Ipamorelin acts in a completely different way than CJC-1295 by mimicking ghrelin. This is an important distinction between both peptides because Ghrelin is responsible for initiating the breakdown of fat for use as energy as well as preventing the breakdown of muscles. Ipamorelin is cleared from the body more rapidly as its half-life is only about 2 hours.

Benefits include: Increased muscle mass and strength, Decrease in body fat, Improved recovery time and Improved sleep quality and cognitive function.